INHIBITION OF THE HIV-1 PROTEASE BY FULLERENE DERIVATIVES - MODEL-BUILDING STUDIES AND EXPERIMENTAL-VERIFICATION

被引:900
|
作者
FRIEDMAN, SH
DECAMP, DL
SIJBESMA, RP
SRDANOV, G
WUDL, F
KENYON, GL
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SANTA BARBARA,DEPT CHEM,SANTA BARBARA,CA 93106
关键词
D O I
10.1021/ja00068a005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The ability of C60 fullerene (''Bucky Ball'') derivatives to interact with the active site of HIV-1 protease (HIVP) has been examined through model building and simple physical chemical analysis. The model complexes generated via the program DOCK3 suggest that C60 derivatives will fit snugly in the active site, thereby removing 298 angstrom2 of primarily nonpolar surface from solvent exposure and driving ligand/protein association. The prediction that these compounds should bind to the active site and thereby act as inhibitors has been borne out by the experimental evidence. Kinetic analysis of HIVP in the presence of a water-soluble C60 derivative, bis(phenethylamino-succinate) C60, suggests a competitive mode of inhibition. This is consistent with and supports the predicted binding mode. Diamino C60 has been proposed as a ''second-generation'' C60 derivative that will be able to form salt bridges with the catalytic aspartic acids in addition to van der Waals contacts with the nonpolar HIVP surface, thereby improving the binding relative to the tested compound.
引用
收藏
页码:6506 / 6509
页数:4
相关论文
共 50 条
  • [2] Inhibition of HIV-1 protease by oxim derivatives
    Komai, T
    Yagi, R
    SuzukiSunagawa, H
    Ishikawa, Y
    Kasuya, A
    Miyamoto, S
    Handa, H
    Nishigaki, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (03) : 557 - 561
  • [3] The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors
    Saleh, Noha A.
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2015, 136 : 1523 - 1529
  • [4] Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease
    Yasuno, Takumi
    Ohe, Tomoyuki
    Kataoka, Hiroki
    Hashimoto, Kosho
    Ishikawa, Yumiko
    Furukawa, Keigo
    Tateishi, Yasuhiro
    Kobayashi, Toi
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
  • [5] COMPETITIVE-INHIBITION OF HIV-1 PROTEASE BY WARFARIN DERIVATIVES
    TUMMINO, PJ
    FERGUSON, D
    HUPE, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (01) : 290 - 294
  • [6] MODEL-BUILDING IN PHARMACOKINETICS .5. SIMULATION OF BLOOD LEVEL CURVES FOLLOWING REPETITIVE DOSING AND THEIR EXPERIMENTAL-VERIFICATION
    HAMMER, R
    BOZLER, G
    HEINZEL, G
    KOSS, FW
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1977, 27 (NA4): : 928 - 931
  • [7] Fullerene-based inhibitors of HIV-1 protease
    Strom, T. Amanda
    Durdagi, Serdar
    Ersoz, Suha Salih
    Salmas, Ramin Ekhteiari
    Supuran, Claudiu T.
    Barron, Andrew R.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2015, 21 (12) : 862 - 870
  • [8] Neutron crystallographic and scattering studies of function and inhibition of HIV-1 protease
    Kovalevsky, Andrey
    Gerlits, Oksana
    Das, Amit
    Wymore, Troy
    Keen, David A.
    Blakeley, Matthew P.
    Louis, John M.
    Weber, Irene
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : A36 - A36
  • [9] Structural and electronic properties of new fullerene derivatives and their possible application as HIV-1 protease inhibitors
    Ibrahim, Medhat
    Saleh, Noha A.
    Hameed, Ali Jameel
    Elshemey, Wael M.
    Elsayed, Anwar A.
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2010, 75 (02) : 702 - 709
  • [10] Thermodynamics of strongly allosteric inhibition: a model study of HIV-1 protease
    S. Kimura
    R. A. Broglia
    G. Tiana
    [J]. European Biophysics Journal, 2012, 41 : 991 - 1001